Research News and Research

RSS

CHADD survey reveals the importance of early diagnosis in treating Attention-Deficit/Hyperactivity Disorder

The results from an informal survey on AD/HD released today reinforce existing scientific research that the disorder does not affect children alone, and when left undiagnosed until adulthood, can create much larger relationship challenges for those with the disorder.

15 Sep 2009

Study describes neuron's two-layer integration model

A new Northwestern University study provides evidence that supports the "two-layer integration model," one of several competing models attempting to explain how neurons integrate synaptic inputs. The findings are published in the journal Neuron.

15 Sep 2009

Possible link between El Ni-o and flu pandemic

Research conducted at Texas A&M University casts doubts on the notion that El Ni-o has been getting stronger because of global warming and raises interesting questions about the relationship between El Ni-o and a severe flu pandemic 91 years ago. The findings are based on analysis of the 1918 El Ni-o, which the new research shows to be one of the strongest of the 20th century.

15 Sep 2009

LLS to invest in research to reduce toxic side-effects of cancer treatment

The cure rates for many cancers have improved dramatically over the past decades, but the harsh reality is that too many cancer survivors suffer serious side-effects of their curative treatments. Toxic side-effects can occur months or years after the treatments are finished, sometimes as chronic conditions, sometimes life-threatening, but always unacceptably reducing a patient's quality of life.

15 Sep 2009

Stem cell therapy holds great promise for regenerative medicine

The recipients of The 2009 Lasker Awards, announced today, represent the dramatic advances achieved in biotechnology research that have led to a revolutionary cancer treatment and the tremendous promise of stem cell therapy for regenerative medicine. Such advances portend a potential $700 million global market for new therapies within less than five years, according to Genetic Engineering & Biotechnology News (GEN, www.genengnews.com).

15 Sep 2009

Researchers study planaria's regeneration process

Amputations trigger a molecular response that determines if a head or tail will be regrown in planaria, a flatworm commonly studied for its regenerative capabilities. Until now, no molecular connection between wounding and the decision to regenerate either a head or tail in planaria had been identified.

15 Sep 2009

Particle beam radiation therapy for cancer cure is better than traditional radiation method

Particle beam radiation therapy, a technology used to treat several types of cancer, is considered by some clinicians to be better than traditional radiation, but there is limited evidence about its safety compared with other types of radiation therapy, according to a new comparative effectiveness report funded by HHS' Agency for Healthcare Research and Quality.

15 Sep 2009

RI-MUHC recommends WHO to revise tuberculosis treatment guidelines

Tuberculosis is a global threat that affects more than 10 million people each year. Working with colleagues in the United States and France, Dr. Dick Menzies of the Research Institute of the McGill University Health Centre (RI-MUHC) has placed current tuberculosis treatment guidelines under the microscope in a new study.

15 Sep 2009

MicroDynamics launches new computer controlled Micro-QC surface inspection microscope

MicroDynamics announces the release of the new MD-MicroQC, a lightweight, durable surface inspection Microscope. This advanced system design, states John Bearden, President and designer, "provides for enhanced performance, reliable results and the versatility to adapt to different production environments." MicroDynamics will be demonstrating the MD-MicroQC at the Quality Expo on September 22 - 24 at booth 4670.

15 Sep 2009

Triamcinolone may be a treatment option for some patients with retinal vein occlusion

Injecting the eye with the corticosteroid triamcinolone appears effective in improving the vision of some patients with retinal vein occlusion, an important cause of vision loss that results from blockages in the blood vessels in the retina, according to two reports in the September issue of Archives of Ophthalmology, one of the JAMA/Archives journals.

15 Sep 2009

Outreach and Registry Program to help combat and treat Alzheimer's disease

Today Senator Jay Rockefeller announced an unprecedented and powerful partnership to help combat and treat Alzheimer's disease in West Virginia.

15 Sep 2009

DHA improves cognitive skills in children

Research has shown that children who were breast fed as infants have superior cognitive skills compared to those fed infant formula, and it's thought that this is due to an essential fatty acid in breast milk called docosahexaenoic acid (DHA). Now a new study has found that babies fed formula supplemented with DHA have higher cognitive skills than babies fed regular formula.

15 Sep 2009

Conserved protein modulates and protects heart function against aging

Investigators at Burnham Institute for Medical Research (Burnham) have found that the conserved protein d4eBP modulates cardiac aging in Drosophila (fruit flies). The team also found that d4eBP, which binds to the protein dEif4e, protects heart function against aging.

15 Sep 2009

NanoBio presents preclinical data of NB-201 for treating burn wounds at the 2009 ICAAC

NanoBio Corporation today announced compelling preclinical data for NB-201, a nanoemulsion-based topical lotion for the treatment of burn wounds. In preclinical studies, NB-201 dramatically reduced the severity of burn wound infections as well as inflammation following thermal injuries. The research was conducted at the University of Michigan Medical School in Ann Arbor as a collaborative effort between the University and NanoBio.

15 Sep 2009

Oil-and-water-based nanoemulsion could be more effective for treating burns

Treating second-degree burns with a nanoemulsion lotion sharply curbs bacterial growth and reduces inflammation that otherwise can jeopardize recovery, University of Michigan scientists have shown in initial laboratory studies.

15 Sep 2009

Dominion develops and validates clinical quantitative assays for tapentadol

Dominion Diagnostics (Dominion) has recently developed and validated one of the first clinical quantitative assays for the drug tapentadol (Nucynta(TM)) performed by liquid chromatography/tandem mass spectrometry (LC/MS/MS). Tapentadol, recently approved for use by the FDA, is a centrally-active analgesic that has demonstrated efficacy in pain relief with improved gastrointestinal tolerability compared to other opioids for pain management.

15 Sep 2009

Studies to focus on treatments for traumatic battlefield injuries

The University of Maryland R Adams Cowley Shock Trauma Center in Baltimore, Md., will serve as one of 12 core clinical centers in a newly established Extremity Trauma Clinical Research Consortium funded by the U.S. Department of Defense.

15 Sep 2009

Medline Industries launches Generation Pink powder-free synthetic exam gloves

As part of its ongoing campaign to raise breast cancer awareness, Medline Industries, Inc., the nation's largest privately held manufacturer and distributor of medical supplies, today announced the launch of its "Generation Pink powder-free synthetic exam glove.

15 Sep 2009

Limited health literacy linked with poorer access to health information

People who struggle with poor reading and math skills experience problems understanding instructions from health care providers and adhering to treatment, according to a new research review.

15 Sep 2009

CTIA issues statement on the health effects of mobile usage

Today, CTIA-The Wireless Association® President and CEO Steve Largent issued the following statement in response to the U.S. Senate Subcommittee on Appropriations for the Departments of Labor, Health and Human Services, Education, and Related Agencies Hearing on “The Health Effects of Cell Phone Use:”

15 Sep 2009